Site identity card

University Hospital Erlangen

Erlangen, Germany
Share

Networks

Clinical Studies (1)

  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • BC 007

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to